Document Detail

Serum Beta-2-microglobulin levels in intrauterine growth-restricted and normal pregnancies.
MedLine Citation:
PMID:  18753761     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: It was the aim of this study to investigate circulating levels of beta(2)-microglobulin (a marker of renal function) in mothers and fetuses/neonates from intrauterine growth-restricted (IUGR, characterized by impaired nephrogenesis) and appropriate for gestational age (AGA) pregnancies. METHODS: Serum beta(2)-microglobulin levels were determined in 40 parturients and their 20 IUGR and 20 AGA fetuses/neonates on postnatal days 1 (N1) and 4 (N4). Comparatively, creatinine concentrations were measured. RESULTS: No significant differences in beta(2)-microglobulin levels were observed between the 2 groups. In both groups, maternal serum beta(2)-microglobulin levels were significantly lower than fetal, N1 and N4 levels (in all cases p < 0.001 in the AGA group and p <or= 0.002 in the IUGR group). In the AGA and IUGR groups, N4 beta(2)-microglobulin levels were significantly elevated compared with fetal (p = 0.004 and p = 0.001, respectively) and N1 levels (p = 0.002 and p = 0.001, respectively). In both groups, maternal and fetal beta(2)-microglobulin levels did not correlate, but beta(2)-microglobulin and creatinine levels positively correlated in maternal and neonatal samples (in all cases r >or= 0.342 and p <or= 0.031). CONCLUSIONS: Serum beta(2)-microglobulin levels do not differ between IUGR and AGA groups, significantly increase after birth and are not associated with gender or gestational age. Furthermore, maternal levels do not correlate with fetal levels, implying the presence of a placental barrier.
Louiza Kontara; Despina D Briana; Stavroula Baka; Maria Boutsikou; Antonios Marmarinos; Dimitrios Gourgiotis; Ariadne Malamitsi-Puchner
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2008-08-28
Journal Detail:
Title:  Fetal diagnosis and therapy     Volume:  24     ISSN:  1421-9964     ISO Abbreviation:  Fetal. Diagn. Ther.     Publication Date:  2008  
Date Detail:
Created Date:  2008-10-21     Completed Date:  2009-01-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9107463     Medline TA:  Fetal Diagn Ther     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  220-4     Citation Subset:  IM    
Copyright Information:
Copyright 2008 S. Karger AG, Basel.
2nd Department of Obstetrics and Gynecology, Neonatal Division, Athens University Medical School, Athens, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / blood
Creatinine / blood
Fetal Blood / metabolism*
Fetal Growth Retardation / blood,  metabolism*,  ultrasonography
Fetus / metabolism*
Gestational Age
Infant, Newborn
Ultrasonography, Prenatal
beta 2-Microglobulin / blood*
Reg. No./Substance:
0/Biological Markers; 0/beta 2-Microglobulin; 60-27-5/Creatinine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Dystrophic calcification of fetal myocardium: a case report.
Next Document:  Survival in primary congenital pulmonary lymphangiectasia with hydrops fetalis.